Your browser doesn't support javascript.
loading
The addition of chemotherapy to adjuvant radiation is associated with inferior survival outcomes in intermediate-risk HPV-negative HNSCC.
Tasoulas, Jason; Lenze, Nicholas R; Farquhar, Douglas; P Schrank, Travis; Shen, Colette; Shazib, M Ali; Singer, Bart; Patel, Shetal; Grilley Olson, Juneko E; Hayes, David N; Gulley, Margaret L; Chera, Bhishamjit S; Hackman, Trevor; Olshan, Andrew F; Weiss, Jared; Sheth, Siddharth.
  • Tasoulas J; Department of Otolaryngology-Head and Neck Surgery, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Lenze NR; Department of Otolaryngology-Head and Neck Surgery, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Farquhar D; Department of Otolaryngology-Head and Neck Surgery, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • P Schrank T; Department of Otolaryngology-Head and Neck Surgery, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Shen C; Department of Radiation Oncology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Shazib MA; Division of Diagnostic Sciences, Adams School of Dentistry, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Singer B; Department of Pathology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Patel S; Division of Medical Oncology, Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Grilley Olson JE; Division of Medical Oncology, Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Hayes DN; Division of Hematology-Oncology, Department of Medicine, University of Tennessee Health Science Center, Memphis, TN, USA.
  • Gulley ML; Department of Pathology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Chera BS; Department of Radiation Oncology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Hackman T; Department of Otolaryngology-Head and Neck Surgery, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Olshan AF; Department of Epidemiology, Gillings School of Global Public Health, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Weiss J; Division of Medical Oncology, Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Sheth S; Division of Medical Oncology, Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Cancer Med ; 10(10): 3231-3239, 2021 05.
Article en En | MEDLINE | ID: mdl-33934525
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Escamosas de Cabeza y Cuello / Neoplasias de Cabeza y Cuello Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Escamosas de Cabeza y Cuello / Neoplasias de Cabeza y Cuello Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article